Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 71 Records) |
Query Trace: Breast Neoplasms and CYP19A1[original query] |
---|
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover. Breast cancer research and treatment 2015 Nov 154 (2): 263-73. Oesterreich Steffi, Henry N Lynn, Kidwell Kelley M, Van Poznak Catherine H, Skaar Todd C, Dantzer Jessica, Li Lang, Hangartner Thomas N, Peacock Munro, Nguyen Anne T, Rae James M, Desta Zeruesenay, Philips Santosh, Storniolo Anna M, Stearns Vered, Hayes Daniel F, Flockhart David |
Predictive markers in elderly patients with estrogen receptor-positive breast cancer treated with aromatase inhibitors: an array-based pharmacogenetic study. The pharmacogenomics journal 2015 Oct . Rumiato E, Brunello A, Ahcene-Djaballah S, Borgato L, Gusella M, Menon D, Pasini F, Amadori A, Saggioro D, Zagonel |
Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Oct . Santa-Maria Cesar A, Blackford Amanda L, Nguyen Anne T, Skaar Todd C, Philips Santosh, Oesterreich Steffi, Rae James M, Desta Zeruesenay, Robarge Jason D, Henry N Lynn, Storniolo Anna Maria V, Hayes Daniel F, Blumenthal Roger S, Ouyang Pamela, Post Wendy S, Flockhart David A, Stearns Ver |
Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial. BMC cancer 2016 16 (1): 283. Kopp Tine Iskov, Jensen Ditte Marie, Ravn-Haren Gitte, Cohen Arieh, Sommer Helle Molgaard, Dragsted Lars Ove, Tjonneland Anne, Hougaard David Michael, Vogel Ul |
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy. The Eurasian journal of medicine 2016 Feb 48 (1): 10-4. Mazzuca Federica, Botticelli Andrea, Mazzotti Eva, La Torre Marco, Borro Marina, Marchetti Luca, Maddalena Chiara, Gentile Giovanna, Simmaco Maurizio, Marchetti Pao |
The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds. Frontiers in genetics 2016 7 211. Armamento-Villareal Reina, Shah Vallabh O, Aguirre Lina E, Meisner Angela L W, Qualls Clifford, Royce Melanie |
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast cancer research : BCR 2016 Nov 18 (1): 110. Johansson Harriet, Gray Kathryn P, Pagani Olivia, Regan Meredith M, Viale Giuseppe, Aristarco Valentina, Macis Debora, Puccio Antonella, Roux Susanne, Maibach Rudolf, Colleoni Marco, Rabaglio Manuela, Price Karen N, Coates Alan S, Gelber Richard D, Goldhirsch Aron, Kammler Roswitha, Bonanni Bernardo, Walley Barbara A, |
Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients. British journal of clinical pharmacology 2016 Oct . Gervasini Guillermo, Jara Carlos, Olier Clara, Romero Nuria, Martínez Ruth, Carrillo Juan Anton |
Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients. Pharmacogenomics 2017 Jun . Sini Valentina, Botticelli Andrea, Lunardi Gianluigi, Gori Stefania, Marchetti Pao |
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
Breast cancer research and treatment 2017 Apr . Dudenkov Tanda M, Ingle James N, Buzdar Aman U, Robson Mark E, Kubo Michiaki, Ibrahim-Zada Irada, Batzler Anthony, Jenkins Gregory D, Pietrzak Tracy L, Carlson Erin E, Barman Poulami, Goetz Matthew P, Northfelt Donald W, Moreno-Aspita Alvaro, Williard Clark V, Kalari Krishna R, Nakamura Yusuke, Wang Liewei, Weinshilboum Richard |
Polymorphism in xenobiotic and estrogen metabolizing genes, exposure to perfluorinated compounds and subsequent breast cancer risk: A nested case-control study in the Danish National Birth Cohort. Environmental research 2017 Jan 154 325-333. Ghisari Mandana, Long Manhai, Røge Durita Mohr, Olsen Jørn, Bonefeld-Jørgensen Eva |
Rs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I-II and operable stage III breast cancer. Oncology letters 2017 Nov 14 (5): 6156-6162. Shao Xiying, Luo Lei, Guo Yong, Xu Xiaohong, Deng Dehou, Feng Jianguo, Ding Yuheng, Mou Hanzhou, Huang Ping, Shi Lei, Huang Yuan, Ye Weiwu, Lou Caijin, Chen Zhanhong, Zheng Yabing, Wang Xiaoj |
Macronutrient intakes and serum oestrogen, and interaction with polymorphisms in CYP19A1 and HSD17B1 genes: a cross-sectional study in postmenopausal Japanese women. The British journal of nutrition 2017 Sep 118 (6): 463-472. Takagi Sahoko, Naito Mariko, Kawai Sayo, Okada Rieko, Nagata Chisato, Hosono Satoyo, Nishida Yuichiro, Takashima Naoyuki, Suzuki Sadao, Shimoshikiryo Ippei, Mikami Haruo, Uemura Hirokazu, Kuriyama Nagato, Ohnaka Keizo, Kubo Michiaki, Hamajima Nobuyuki, Tanaka Hideo, Wakai Ken |
[Association of CYP19A1 gene rs7176005 single nucleotide polymorphism with breast cancer risk and clinicopathologic features of tumor]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2018 Aug 52 (8): 827-832. Du Z G, Wang L Y, Zhou Y, Wan H Y, Liang F Q, Lyu |
Genetic Variations, Exposure to Persistent Organic Pollutants and Breast Cancer Risk - A Greenlandic Case-Control Study. Basic & clinical pharmacology & toxicology 2018 Mar . Wielsøe Maria, Eiberg Hans, Ghisari Mandana, Kern Peder, Lind Ole, Bonefeld-Jørgensen Eva Cecil |
Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer. Hormones & cancer 2018 Jan . Friesenhengst Andrea, Pribitzer-Winner Tamara, Miedl Heidi, Pröstling Katharina, Schreiber Mart |
Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population. BMC medical genetics 2019 Sep 20 (1): 148. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
Association of CYP19A1 single-nucleotide polymorphism with digit ratio (2D:4D) in a sample of men and women from Ningxia (China). Early human development 2019 Apr 132 58-65. Zhanbing Ma, Jie Dang, Chunyue Bai, Hong Lu, Liang Peng, Zhenghao H |
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer. The pharmacogenomics journal 2019 Apr . Johansson Harriet, Aristarco Valentina, Gandini Sara, Gjerde Jennifer, Macis Debora, Guerrieri-Gonzaga Aliana, Serrano Davide, Lazzeroni Matteo, Rajasekaran Agnita, Williard Clark V, Mellgren Gunnar, DeCensi Andrea, Bonanni Bernar |
Polymorphisms in Phase I (CYP450) Genes CYP1A1 (rs4646421), CYP1B1 (rs1056836), CYP19A1 (rs749292) and CYP2C8 (rs1058930) and Their Relation to Risk of Breast Cancer: A Case-Control Study in Mazandaran Province in North of Iran. Open access Macedonian journal of medical sciences 2019 Aug 7 (15): 2488-2496. Golmohammadzadeh Golpar, Mohammadpour Abbas, Ahangar Nematollah, Shokrzadeh Mohamm |
Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 9 26 (23): 6254-6265. Richard François, Majjaj Samira, Venet David, Rothé Françoise, Pingitore Julien, Boeckx Bram, Marchio Caterina, Clatot Florian, Bertucci François, Mariani Odette, Galant Christine, Eynden Gert van den, Salgado Roberto, Biganzoli Elia, Lambrechts Diether, Vincent-Salomon Anne, Pruneri Giancarlo, Larsimont Denis, Sotiriou Christos, Desmedt Christi |
Genetic and clinical predictors of arthralgia during letrozole or anastrozole therapy in breast cancer patients. Breast cancer research and treatment 2020 Jul . Borrie Adrienne E, Rose Finnley A, Choi Yun-Hee, Perera Francisco E, Read Nancy, Sexton Tracy, Lock Michael, Vandenberg Theodore A, Hahn Karin, Younus Jawaid, Logan Diane, Potvin Kylea, Yaremko Brian, Yu Edward, Lenehan John, Welch Stephen, Teft Wendy A, Kim Richard |
Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity. Breast cancer research and treatment 2020 May . Umamaheswaran Gurusamy, Kadambari Dharanipragada, Muthuvel Suresh Kumar, Kalaivani Sekar, Devi Jaganathan, Damodaran Solai Elango, Pradhan Suresh Chandra, Dubashi Biswajit, Dkhar Steven Aibor, Adithan Chandrasekar |
Urinary bisphenol A and its interaction with CYP17A1 rs743572 are associated with breast cancer risk. Chemosphere 2021 Aug 286 (Pt 3): 131880. He Heng, Deng Yao, Wan Hao, Shen Na, Li Jiaoyuan, Zeng Qiang, Chang Jiang, Lu Qing, Miao Xiaoping, Tian Jianbo, Zhong Ro |
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer. Frontiers in genetics 2021 12 662734. Hertz Daniel L, Smith Karen Lisa, Zong Yuhua, Gersch Christina L, Pesch Andrea M, Lehman Jennifer, Blackford Amanda L, Henry N Lynn, Kidwell Kelley M, Rae James M, Stearns Ver |
The CYP19A1 rs700519 Polymorphism and Breast Cancer Susceptibility in China: A Case-Control Study and Updated Meta-Analysis. Genetic testing and molecular biomarkers 2021 7 25 (7): 486-495. Lv Fei, Huang Wanying, Wang Yi |
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study. Frontiers in oncology 2021 6 11 642768. Tryggvadottir Helga, Sandén Emma, Björner Sofie, Bressan Alessandra, Ygland Rödström Maria, Khazaei Somayeh, Edwards Dean P, Nodin Björn, Jirström Karin, Isaksson Karolin, Borgquist Signe, Jernström Hele |
The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis. Molecular genetics & genomic medicine 2021 May e1705. Alwan Ahmad Mohammed, Afzaljavan Fahimeh, Tavakol Afshari Jalil, Homaei Shandiz Fatemeh, Barati Bagherabad Matineh, Vahednia Elham, Kheradmand Nahid, Pasdar Alire |
Urinary concentration of endocrine-disrupting phthalates and breast cancer risk in Indian women: A case-control study with a focus on mutations in phthalate-responsive genes. Cancer epidemiology 2022 6 79 102188. Mukherjee Das Ankan, Gogia Ajay, Garg Manoj, Elaiyaraja Arun, Arambam Priyadarshini, Mathur Sandeep, Babu-Rajendran Ramaswamy, Deo S V S, Kumar Lalit, Das Bhudev C, Janardhanan Raj |
A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 4 . Vered Stearns, Opeyemi A Jegede, Victor Tsu-Shih Chang, Todd C Skaar, Jeffrey L Berenberg, Ranveer Nand, Atif Shafqat, Nisha Lassi Jacobs, William Luginbuhl, Paul Gilman, Al B Benson, Judie R Goodman, Gary L Buchschacher, N Lynn Henry, Charles L Loprinzi, Patrick J Flynn, Edith P Mitchell, Michael Jordan Fisch, Joseph A Sparano, Lynne I Wagn |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 11, 2024
- Content source: